Morgane Lacour

APP, PSEN1, and PSEN2 mutations in early-onset Alzheimer disease: A genetic screening study of familial and sporadic cases

Olivier Rouaud, Canan Ozsancak, Valérie Chauviré, 2017, PLoS medicine.

Penetrance estimation of Alzheimer disease in SORL1 loss-of-function variant carriers using a family-based strategy and stratification by APOE genotypes

W. M. van der Flier, D. Grozeva, O. Martinaud, 2022, Genome Medicine.

Penetrance estimation of Alzheimer disease in SORL1 loss-of-function variant carriers using a family-based strategy and stratification by APOE genotypes

Nick C Fox, W. M. van der Flier, A. Uitterlinden, 2022, Genome Medicine.

Publisher Correction: Penetrance estimation of Alzheimer disease in SORL1 loss-of-function variant carriers using a family-based strategy and stratification by APOE genotypes

D. Campion, D. Wallon, A. Boland, 2022, Genome medicine.

Causative Mutations and Genetic Risk Factors in Sporadic Early Onset Alzheimer's Disease Before 51 Years.

J. Pariente, F. Pasquier, O. Martinaud, 2019, Journal of Alzheimer's disease : JAD.

Penetrance estimation of SORL1 loss-of-function variants using a family-based strategy adjusted on APOE genotypes suggest a non-monogenic inheritance

D. Campion, D. Wallon, A. Boland, 2021, bioRxiv.

Assessment of Mendelian and risk factor genes in Alzheimer disease: a prospective nationwide clinical utility study and recommendations for genetic screening.

O. Martinaud, K. Bennys, V. de la Sayette, 2024, Genetics in medicine : official journal of the American College of Medical Genetics.